Impact and economic evaluation of a novel HIV service delivery model in rural Malawi
OBJECTIVE:We performed an impact and cost-effectiveness analysis of a novel HIV service delivery model in a high prevalence, remote district of Malawi with a population of 143 800 people. DESIGN:A population-based retrospective analysis of 1-year survival rates among newly enrolled HIV-positive pati...
Gespeichert in:
Veröffentlicht in: | AIDS (London) 2017-09, Vol.31 (14), p.1999-2006 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | OBJECTIVE:We performed an impact and cost-effectiveness analysis of a novel HIV service delivery model in a high prevalence, remote district of Malawi with a population of 143 800 people.
DESIGN:A population-based retrospective analysis of 1-year survival rates among newly enrolled HIV-positive patients at 682 health facilities throughout Malawi, comparing facilities implementing the service delivery model (n = 13) and those implementing care-as-usual (n = 669).
METHODS:Through district-level health surveillance data, we evaluated 1-year survival rates among HIV patients newly enrolled between July 2013 and June 2014 – representing 129 938 patients in care across 682 health facilities – using a multilevel modeling framework. The model, focused on social determinants of health, was implemented throughout Neno District at 13 facilities and compared with facilities in all other districts. Activity-based costing was used to annualize financial and economic costs from a societal perspective. Incremental cost-effectiveness ratios were expressed as quality-adjusted life-years gained.
RESULTS:The national average 1-year survival rate for newly enrolled antiretroviral therapy clients was 78.9%this rate was 87.9% in Neno District, compared with 78.8% across all other districts in Malawi (P |
---|---|
ISSN: | 0269-9370 1473-5571 |
DOI: | 10.1097/QAD.0000000000001578 |